The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery
Status:
Not yet recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The prognosis of patients undergoing spinal deformity surgery is often compromised by
perioperative anemia due to iron deficiency. The aim of this randomized, controlled trial was
to evaluate whether postoperative i.v. ferric derisomaltose may improve anemia and prognosis
in patients undergoing spinal deformity surgery comparing with oral iron. Participants will
be randomly assigned to the treatment group (intravenous ferric derisomaltose) and the
control group (oral iron). Changes in hemoglobin concentration, percentage of anemia
correction, changes in iron indicators, patient quality of life, and incidence of adverse
events will be analyzed to evaluate the efficacy and safety of iron isomaltoside infusion.